Yuval Cohen is CEO at Corbus Pharmaceuticals Holdings, Inc. (CRBP). They have made 25 open-market trades across 1 company since 2014, most recently 2026-08-07.
CIK 0001626003
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
25 open-market purchases totalling $149K since 2014, never a sale. Across 25 scored buys the stock is up 6.0% at ninety days, and 2.8 points ahead of the S&P over the same stretch.
25 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CRBP | 157,316 | $709K |
Shares reported on the most recent Form 4, priced at the 2026-08-10 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 32% | 32% |
| Avg Move | -3.5% | +1.4% | +6.0% |
| Alpha | -2.0% | -0.3% | +2.8% |
| Scored | 25 | 25 | 25 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRBP | SELL · 10b5-1 | 2026-08-07 | 2026-08-10 | $10.08 | $171K | +2.5% | -8.0% | — |
| CRBP | SELL · 10b5-1 | 2026-02-13 | 2026-02-18 | $7.78 | $108K | +12.7% | +16.3% | +25.1% |
| CRBP | SELL · 10b5-1 | 2025-10-24 | 2025-10-27 | $17.05 | $942K | -38.9% | -30.5% | -45.4% |
| CRBP | SELL · 10b5-1 | 2025-02-14 | 2025-02-18 | $8.76 | $125K | -6.9% | -26.0% | -4.3% |
| CRBP | SELL · 10b5-1 | 2024-06-14 | 2024-06-18 | $46.57 | $5.9M | +13.9% | +22.3% | +24.2% |
| CRBP | BUY | 2022-08-10 | 2022-08-11 | $0.26 | $988 | -20.2% | -18.6% | -52.8% |
| CRBP | BUY | 2022-05-16 | 2022-05-16 | $0.25 | $3K | +6.2% | -7.0% | -9.1% |
| CRBP | BUY | 2022-03-09 | 2022-03-09 | $0.37 | $3K | +23.9% | +8.9% | -23.5% |
| CRBP | BUY | 2020-11-11 | 2020-11-12 | $1.21 | $5K | -12.2% | +0.0% | +145.7% |
| CRBP | BUY | 2020-03-17 | 2020-03-17 | $3.49 | $15K | +33.7% | +44.7% | +83.7% |
| CRBP | BUY | 2019-11-12 | 2019-11-12 | $4.26 | $6K | +6.3% | +17.9% | +45.9% |
| CRBP | BUY | 2019-08-12 | 2019-08-12 | $6.06 | $7K | -6.7% | -5.3% | -26.5% |
| CRBP | BUY | 2019-05-13 | 2019-05-14 | $6.99 | $7K | +1.5% | -1.3% | -16.6% |
| CRBP | BUY | 2019-03-14 | 2019-03-14 | $6.49 | $10K | +4.4% | +4.1% | +0.0% |
| CRBP | BUY | 2018-05-15 | 2018-05-16 | $5.85 | $10K | -4.8% | -1.6% | -21.8% |
| CRBP | BUY | 2018-03-14 | 2018-03-15 | $6.89 | $8K | -14.2% | -3.6% | -10.2% |
| CRBP | BUY | 2017-11-10 | 2017-11-13 | $7.17 | $7K | +2.2% | +5.1% | +2.9% |
| CRBP | BUY | 2017-08-11 | 2017-08-11 | $6.00 | $10K | -1.6% | +5.6% | +12.8% |
| CRBP | BUY | 2017-05-11 | 2017-05-12 | $6.01 | $20K | +4.7% | -7.8% | -9.3% |
| CRBP | BUY | 2016-11-22 | 2016-11-23 | $7.64 | $10K | +0.6% | +9.6% | +12.2% |
| CRBP | BUY | 2016-06-06 | 2016-06-07 | $3.34 | $5K | -8.4% | -8.8% | +48.4% |
| CRBP | BUY | 2016-05-18 | 2016-05-19 | $2.40 | $5K | +42.7% | +16.9% | +28.6% |
| CRBP | BUY | 2015-11-23 | 2015-11-24 | $1.76 | $942 | -18.1% | -3.0% | -15.1% |
| CRBP | BUY | 2015-11-13 | 2015-11-16 | $1.73 | $1K | -18.1% | -3.0% | -27.1% |
| CRBP | BUY | 2015-08-24 | 2015-08-25 | $1.95 | $1K | -18.1% | -3.0% | -3.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.